0001237899-21-000018.txt : 20210824
0001237899-21-000018.hdr.sgml : 20210824
20210824160603
ACCESSION NUMBER: 0001237899-21-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210820
FILED AS OF DATE: 20210824
DATE AS OF CHANGE: 20210824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAROSA JOSEPH J
CENTRAL INDEX KEY: 0001238303
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211202266
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-20
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001238303
LAROSA JOSEPH J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP General Counsel and Secret
Common Stock
2021-08-20
4
M
0
10000
179.13
A
23182
D
Common Stock
2021-08-20
4
F
0
6575
664.85
D
16607
D
Common Stock
2021-08-23
4
S
0
3383
661.8
D
13224
D
Common Stock
2021-08-23
4
S
0
41
665.4
D
13183
D
Common Stock
2021-08-23
4
S
0
1
666.22
D
13182
D
Common Stock
3186
I
2021 GRAT
Common Stock
314
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
179.13
2021-08-20
4
M
0
10000
0.0
D
2022-12-14
Common Stock
10000
30000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Joseph LaRosa
2021-08-23